HR 679 · 119th Congress
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Latest action
2025-01-23 — Referred to the House Committee on Energy and Commerce.
Sponsor
Diana HarshbargerCosponsors
Cosponsors not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-679
to populate.
Action history
Action history not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-679
to populate.
Subjects
Subjects not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-679
to populate.
Titles
Titles not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-679
to populate.
Summaries
Summaries not yet fetched. Run
concord scrape bills enrich --bill-ids 119-hr-679
to populate.
Vote history
No votes recorded for this bill yet.
Coming in later phases
Committee path (Phase 4)
Committee referrals and reports will appear here.
Search within this bill (Phase 5)
Bill text will become searchable here.